MAZE
LIVE

Serial Number

50135967

Owner

Maze Therapeutics, Inc.

Attorney

Joyce Liou

Filing Date

Sep 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MAZE Trademark

Serial Number: 50135967

MAZE is a trademark filed by Maze Therapeutics, Inc. on September 29, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Maze Therapeutics, Inc. (5 trademarks)

171 Oyster Point Boulevard, Suite 300
San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

September 29, 2026

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for treating genetic diseases and disorders; pharmaceutical preparations for treating lysosomal storage disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system, and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention and treatment of obesity; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; reagents for medical use; genetic testing preparations for medical purposes, namely, medical diagnostic reagents and assays for testing of body fluids; cells for medical or clinical use; medical diagnostic and testing assays, namely, medical diagnostic reagents and assays for testing of body fluids

Providing information in the field of genetic modifiers and related therapeutics for genetic diseases; providing information in the field of genetic variations linked to medical diseases or conditions; providing information in the field of variant functionalization

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 29, 2026 MAFR
NEW APPLICATION ENTERED
Sep 29, 2026 NWAP